Nantahala Capital Management, LLC

Position in VSTM — Verastem, Inc.

CIK 1472322 New Canaan, CT

Position in VSTM

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$18,999,546

+$15,431,826 QoQ

Shares Held

3,584,820

+675.7% QoQ

Ownership

4.08%

of shares outstanding

% of Portfolio

1.14%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2024

8 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Nantahala Capital Management, LLC holds $599,967,806 across 52 Biotechnology names. VSTM ranks #10 (3.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	SLNO	Soleno Therapeutics Inc	1,744,124	$58,393,271
2	SVRA	Savara Inc	7,344,783	$40,102,515
3	IMUX	Immunic, Inc.	2,506,491	$27,822,050
4	TNGX	Tango Therapeutics, Inc.	1,250,452	$26,159,455
5	LBRX	Lb Pharmaceuticals Inc	1,052,894	$25,964,366
6	MLYS	Mineralys Therapeutics, Inc.	895,481	$24,258,580
7	ZVRA	Zevra Therapeutics, Inc.	2,521,936	$23,504,443
8	FULC	Fulcrum Therapeutics, Inc.	3,050,040	$23,393,806

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$18,999,546	3,584,820	-5.6%	Shares	Sole	2026-05-15
2025-12-31	$29,301,051	3,795,473	+721.3%	Shares	Sole	2026-02-13
2025-12-31	$3,567,720	462,140	-64.3%	Shares	Sole	2026-02-13
2025-09-30	$11,416,333	1,292,903	-56.2%	Shares	Sole	2025-11-14
2025-06-30	$12,262,150	2,954,735	+28.5%	Shares	Sole	2025-08-14
2025-03-31	$13,860,202	2,298,541	-38.7%	Shares	Sole	2025-05-15
2024-12-31	$19,400,854	3,752,583	+0.5%	Shares	Sole	2025-02-14
2024-09-30	$11,162,665	3,733,333	+833.3%	Shares	Sole	2024-11-14
2024-06-30	$1,192,000	400,000	—	Shares	Sole	2024-08-20
No filing history on record for this holder in this stock.